Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Search
Who we are
How to use and read
Pharma World
Business
Global report
Regulatory
Pharmacovigilance
Manufacturing
GMP
Quality assurance
R&D
API
Excipients
Trials
Drug Delivery
Technology
Companies
Contract manufacturing
Equipment
Outsourcing
Packaging
Supply chain
Technology Transfer
EIPG Newsletter
Technology & Production
Regulatory
Politics & Business
Focus on EU’s Countries
News from EIPG
Home
EIPG Newsletter
Regulatory
Regulatory
The importance of early interactions between regulators and pharma industry
Giuliana Miglierini
-
18 June 2020
0
How the EU Commission and the European medicines regulatory network are...
Giuliana Miglierini
-
20 May 2020
0
New guidances for gene therapy
Giuliana Miglierini
-
17 April 2020
0
Time to innovate the EU variation system
Giuliana Miglierini
-
26 March 2020
0
The principles to develop ePI
Giuliana Miglierini
-
20 February 2020
0
EMA’s view on Pharmacovigilance in 2030
Giuliana Miglierini
-
21 January 2020
0
Revised guidelines on the use of genetics and genetic testing in...
Giuliana Miglierini
-
10 December 2019
0
EMA’s view on method validation
Giuliana Miglierini
-
20 November 2019
0
A Staff Working Document on EMA’s fees published by the EU...
Giuliana Miglierini
-
16 October 2019
0
Latest advancements in the EU-US Mutual Recognition Agreement for Pharmaceuticals
Giuliana Miglierini
-
18 September 2019
0
1
2
3
4
Page 1 of 4
